BIIB vs CW · P/E 21, rev $9.89B vs P/E 43, rev $1.84B
Biogen Inc (BIIB) versus Curtiss-Wright Corporation (CW) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Curtiss-Wright Corporation (CW) is a aerospace & defense company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported CW revenue for 2026-06-30 was $1.84B. Net income was $279.4M. CW currently screens at market cap $18.20B and trailing P/E 42.9.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. CW currently screens at market cap $18.20B and trailing P/E 42.9.
Not investment advice. Open the BIIB and CW stock pages for the full models.
Not investment advice.